Due to fraudulence and misconduct in research, advances in Alzheimer’s Disease treatments have been hindered. Read More.
Other Posts
Who Gets to Edit the Future?
Scientists are continuing to explore the use of CRISPR gene-editing technology in human embryos to prevent the transmission of inherited genetic diseases. While the research demonstrates the potential to reduce the burden of serious hereditary [...]
Beyond the Outbreak: What Ebola Reveals About Preparedness and Response
A growing Ebola outbreak in Uganda has prompted the Trump administration to reconsider how the United States coordinates its global response. As cases continue to rise, administration officials have discussed appointing a dedicated coordinator while [...]
From Breakthrough to Access: The Next Challenge for HIV Prevention
The new HIV prevention drug lenacapavir is beginning to reach communities in Zambia, offering new hope in the global fight against HIV. Administered just twice a year, the injectable medication has demonstrated near-complete effectiveness in [...]
From Lifelong Management to the Possibility of Cure
A new study published in the New England Journal of Medicine found that bepirovirsen, an experimental hepatitis B treatment, achieved a functional cure in about 1 in 5 patients with chronic hepatitis B after a [...]
WHO Experts Review Promising Treatments and Vaccines for Bundibugyo Ebola
As an Ebola disease outbreak continues in the Democratic Republic of the Congo and Uganda, the WHO has identified several promising treatments and vaccines for further study. Experts are prioritizing a select group of therapies [...]
Teams of AI agents boost speed of research
AI has been used to generate hypotheses and identify targets in drug discovery teams. Though AI is still not able to fully carry out tests and data analysis for all research applications, it has a [...]
